Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system.

Wang A, Guo M, Wang N, Zhao J, Qi W, Muhammad F, Chen L, Guo Y, Nguyen NT, Zhu G.

Nanoscale. 2014 May 21;6(10):5270-8. doi: 10.1039/c3nr05687b.

PMID:
24695417
2.

Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.

Li X, Zhao W, Liu X, Chen K, Zhu S, Shi P, Chen Y, Shi J.

Acta Biomater. 2016 Jan;30:378-387. doi: 10.1016/j.actbio.2015.11.036. Epub 2015 Nov 18.

PMID:
26602820
3.

Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.

Chen Y, Chen H, Zhang S, Chen F, Sun S, He Q, Ma M, Wang X, Wu H, Zhang L, Zhang L, Shi J.

Biomaterials. 2012 Mar;33(7):2388-98. doi: 10.1016/j.biomaterials.2011.11.086. Epub 2011 Dec 16.

PMID:
22177841
4.

Intracellular antioxidants dissolve man-made antioxidant nanoparticles: using redox vulnerability of nanoceria to develop a responsive drug delivery system.

Muhammad F, Wang A, Qi W, Zhang S, Zhu G.

ACS Appl Mater Interfaces. 2014;6(21):19424-33. doi: 10.1021/am5055367. Epub 2014 Oct 22.

PMID:
25312332
5.

Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.

Kim MH, Son HY, Kim GY, Park K, Huh YM, Haam S.

Biomaterials. 2016 Sep;101:121-30. doi: 10.1016/j.biomaterials.2016.05.054. Epub 2016 Jun 1.

PMID:
27281684
6.
7.

Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.

Hao Y, Wang L, Zhang B, Li D, Meng D, Shi J, Zhang H, Zhang Z, Zhang Y.

Int J Nanomedicine. 2016 Apr 29;11:1759-78. doi: 10.2147/IJN.S98832. eCollection 2016.

8.

Facile synthesis and functionalization of manganese oxide nanoparticles for targeted T1-weighted tumor MR imaging.

Luo Y, Yang J, Li J, Yu Z, Zhang G, Shi X, Shen M.

Colloids Surf B Biointerfaces. 2015 Dec 1;136:506-13. doi: 10.1016/j.colsurfb.2015.09.053. Epub 2015 Sep 30.

PMID:
26454057
9.

Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.

Chen Y, Yin Q, Ji X, Zhang S, Chen H, Zheng Y, Sun Y, Qu H, Wang Z, Li Y, Wang X, Zhang K, Zhang L, Shi J.

Biomaterials. 2012 Oct;33(29):7126-37. doi: 10.1016/j.biomaterials.2012.06.059. Epub 2012 Jul 11.

PMID:
22789722
10.

Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.

Guillet-Nicolas R, Laprise-Pelletier M, Nair MM, Chevallier P, Lagueux J, Gossuin Y, Laurent S, Kleitz F, Fortin MA.

Nanoscale. 2013 Dec 7;5(23):11499-511. doi: 10.1039/c3nr02969g. Epub 2013 Oct 31.

PMID:
24178890
11.

Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.

Hu H, Dai A, Sun J, Li X, Gao F, Wu L, Fang Y, Yang H, An L, Wu H, Yang S.

Nanoscale. 2013 Nov 7;5(21):10447-54. doi: 10.1039/c3nr03490a. Epub 2013 Sep 13.

PMID:
24057072
12.

Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.

Sahoo B, Devi KS, Dutta S, Maiti TK, Pramanik P, Dhara D.

J Colloid Interface Sci. 2014 Oct 1;431:31-41. doi: 10.1016/j.jcis.2014.06.003. Epub 2014 Jun 11.

PMID:
24980623
13.

pH dictates the release of hydrophobic drug cocktail from mesoporous nanoarchitecture.

Muhammad F, Wang A, Guo M, Zhao J, Qi W, Yingjie G, Gu J, Zhu G.

ACS Appl Mater Interfaces. 2013 Nov 27;5(22):11828-35. doi: 10.1021/am4035027. Epub 2013 Nov 5.

PMID:
24138477
14.

pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.

Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y, Zhu G.

J Am Chem Soc. 2011 Jun 15;133(23):8778-81. doi: 10.1021/ja200328s. Epub 2011 May 23.

PMID:
21574653
15.

Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.

Shin J, Anisur RM, Ko MK, Im GH, Lee JH, Lee IS.

Angew Chem Int Ed Engl. 2009;48(2):321-4. doi: 10.1002/anie.200802323. No abstract available.

PMID:
19040234
16.

L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.

McDonagh BH, Singh G, Hak S, Bandyopadhyay S, Augestad IL, Peddis D, Sandvig I, Sandvig A, Glomm WR.

Small. 2016 Jan 20;12(3):301-6. doi: 10.1002/smll.201502545. Epub 2015 Nov 30.

PMID:
26619158
17.

Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.

Zhao Z, Wang X, Zhang Z, Zhang H, Liu H, Zhu X, Li H, Chi X, Yin Z, Gao J.

ACS Nano. 2015 Mar 24;9(3):2749-59. doi: 10.1021/nn506640h. Epub 2015 Feb 18.

PMID:
25688714
18.

The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.

Huang CC, Khu NH, Yeh CS.

Biomaterials. 2010 May;31(14):4073-8. doi: 10.1016/j.biomaterials.2010.01.087. Epub 2010 Feb 9.

PMID:
20149451
19.

Electroless Pt deposition on Mn3O4 nanoparticles via the galvanic replacement process: electrocatalytic nanocomposite with enhanced performance for oxygen reduction reaction.

Kim KW, Kim SM, Choi S, Kim J, Lee IS.

ACS Nano. 2012 Jun 26;6(6):5122-9. doi: 10.1021/nn300782m. Epub 2012 May 11.

PMID:
22578142
20.

A comparative study of spinel structured Mn3O4, Co3O4 and Fe3O4 nanoparticles in catalytic oxidation of phenolic contaminants in aqueous solutions.

Saputra E, Muhammad S, Sun H, Ang HM, Tadé MO, Wang S.

J Colloid Interface Sci. 2013 Oct 1;407:467-73. doi: 10.1016/j.jcis.2013.06.061. Epub 2013 Jul 9.

PMID:
23891446

Supplemental Content

Support Center